在接受免疫球蛋白替代疗法的原发性免疫缺陷患者中,针对呼吸道病原体的疫苗接种
Makbule Seda Bayrak Durmaz1, Reyhan Yıldız1, Göksal Keskin1
1Division of Immunology and Allergy, Department of Internal Medicine, Ankara University Faculty of Medicine, Ankara, Türkiye.
Tuberkuloz ve toraks
|April 27, 2024
概括
接种疫苗对于患有天生的免疫缺陷 (IEI) 患者至关重要. 这项研究发现,在接受免疫球蛋白替代疗法 (IGRT) 的IEI患者中,COVID-19疫苗接种率更高,强调个性化疫苗决定.
科学领域:
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
背景情况:
- 免疫的先天性错误 (IEI) 显著增加了严重的呼吸道感染和死亡的风险.
- 接种疫苗是IEI患者的关键预防策略,以减轻与感染相关的并发症.
- 免疫球蛋白替代疗法 (IGRT) 是许多IEI患者的常见治疗方法,可能会影响免疫反应和疫苗接种效率.
研究的目的:
- 在接受IGRT的IEI患者队列中调查接种疫苗和呼吸道感染的发生率.
- 为了在这个特定的患者群体中比较流感,肺炎球菌和COVID-19疫苗的接种率.
- 探索影响IEI患者接种疫苗的决定和结果的因素.
主要方法:
- 在第三级护理中心接受IGRT的IEI患者的回顾性评估.
- 从电子医疗记录中提取疫苗接种状态和呼吸道感染数据.
- 对人口统计和临床特征的分析,包括诊断和伴随性疾病,如支气管病变.
主要成果:
- 这项研究包括33名IEI患者 (平均年龄为37.7岁),主要患有初级抗体缺乏症 (90.9%).
- 疫苗接种率为流感的42.4%,肺炎球菌的57.6%,COVID-19的78.8%.
- 观察到COVID-19疫苗的吸收率明显更高,这归因于与流行病相关的意识和公共卫生信息.
结论:
- 在接受IGRT的IEI患者中,COVID-19疫苗接种率明显高于流感和肺炎球菌疫苗.
- 虽然社会和政府的影响可以促进疫苗接种,但对IEI患者疫苗接种策略来说,个性化评估至关重要.
- 这些发现强调了需要制定量身定制的疫苗接种计划,考虑到IEI患者独特的免疫特征.
相关概念视频
Humoral Immune Responses
72.6K
Overview
72.6K
Vaccinations
44.4K
Overview
44.4K
Immunodeficiency Diseases
936
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
936
Transmission-based Precautions II: Airborne and Protective Environment
1.2K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.2K
Development of Immunocompetence
305
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
305
Acute Respiratory Failure-V
136
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
136


